Pfizer Inc(PFE) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 23 at 7:52 PM ET (Korea 10/24 08:52)
Full metrics table
| Index | S&P 500 | P/E | 39.76 | EPS (ttm) | 0.76 | Insider Own | 0.09% | Shs Outstand | 5.70B | Perf Week | 1.52% |
| Market Cap | 171.16B | Forward P/E | 10.38 | EPS next Y | -2.01% | Insider Trans | 2.18% | Shs Float | 5.69B | Perf Month | 5.7% |
| Enterprise Value | 222.96B | PEG | - | EPS next Q | 0.73 | Inst Own | 69.71% | Short Float | 2.64% | Perf Quarter | 21.73% |
| Income | 4.33B | P/S | 2.69 | EPS this Y | -8.29% | Inst Trans | -0.48% | Short Ratio | 4.36 | Perf Half Y | 11.22% |
| Sales | 63.70B | P/B | 2.01 | EPS next 5Y | -8.34% | ROA | 2.13% | Short Interest | 150.22M | Perf YTD | 20.6% |
| Book/sh | 14.95 | P/C | 14.63 | EPS past 3/5Y | -37.19% -3.57% | ROE | 4.99% | 52W High | -1.35% ($30.44) | Perf Year | 21.73% |
| Cash/sh | 2.05 | P/FCF | 15.58 | Sales past 3/5Y | -14.56% 8.48% | ROIC | 2.97% | 52W Low | 27.14% ($23.62) | Perf 3Y | -2.63% |
| Dividend Est. | $1.72 (5.74%) | EV/EBITDA | 9.48 | EPS Y/Y TTM | -59.71% | Gross Margin | 64.83% | Volatility(W/M) | 1.73% 1.86% | Perf 5Y | -30.42% |
| Dividend TTM | 1.72 | EV/Sales | 3.5 | Sales Y/Y TTM | -0.21% | Oper. Margin | 26.57% | ATR (14) | 0.56 | Perf 10Y | -1.53% |
| Dividend Ex-Date | 2026/11/6 | Quick Ratio | 0.96 | EPS Q/Q | -108.6% | Profit Margin | 6.8% | RSI (14) | 65.55 | Recom | 2.66 |
| Dividend Gr. 3/5Y | 2.23% 2.37% | Current Ratio | 1.27 | Sales Q/Q | 2.6% | SMA20 | 4.32% ($28.79) | Beta | 0.27 | Target Price | $28.99 |
| Payout | 126.85% | Debt/Eq | 0.74 | Earnings | 2026/11/3 | SMA50 | 6.13% ($28.3) | Rel Volume | 0.86 | Prev Close | $30.42 |
| Employees | 75000 | LT Debt/Eq | 0.71 | EPS/Sales Surpr. | 12.87% 4.41% | SMA200 | 12.54% ($26.68) | Avg Volume(3M) | 34.48M | Price | $30.03 |
| IPO | 1944/1/17 | Option/Short | Yes/Yes | Trades | 81506 | Volume | 29,484,166 | Change | -1.28% |
💊 A global, diversified pharmaceutical company covering a wide range of therapeutic areas, including oncology, internal medicine, vaccines, and anti-infectives. Founded in 1849 and headquartered in the U.S., it has established itself as a key player among the global Big Pharma groups.
Over the past 1 year, on the higher side
1% below its 1-year high.
Traded about as much as usual. That is 86% of its average volume.
Next earnings report: November 3
8 days to go. The ex-dividend date is November 6.
PFE earns at a steady pace
Of every $100 in sales, $26.57 is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -8.3% this year.
Tap to view numbers
The price is about the industry average
Counting its debt, for $100 of yearly operating cash you would pay $948. Peers typically go for $1,463. Compared with its own 5-year average, it is 169% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -30.4%. The S&P 500 did +68% over the same period.
Tap to view numbers
Dividends are more than it earns
It pays out 127% of what it earns.
Tap to view numbers
Ownership looks stable
Institutions hold 69.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #9 of 21 in the industry
Based on market cap of $171B.
Earnings Analysis · 8/4 Pfizer ($PFE) Q2 2026 Earnings Analysis — Adjusted EPS and Revenue Both Beat, Full-Year Revenue Outlook Raised, Shares Slightly Weaker After Hours Investing Guides · 4/11 2026 U.S. High-Dividend Stock Guide — How to Screen Out the Traps Investing Guides · 4/1 US Stock Taxes Complete Guide 2026 — Calculation Methods and Tax-Saving Strategies for Beginners See all posts on this stock FAQ
What kind of company is PFE?
PFE belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is the market cap of PFE?
The market cap of PFE is approximately $171.2B, ranking 93 within its sector.
Does PFE pay dividends?
PFE has a dividend yield of approximately 5.74%, with an annual dividend of $1.72.
What is the P/E ratio of PFE?
PFE has a P/E ratio of approximately 39.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for PFE?
PFE has recorded a 52-week high of $30.44 and a low of $23.62.
